Kidney care firm Strive Health scored a whopping $166 million in Collection C funding led by NEA alongside strategic investor CVS Well being Ventures.
Present traders CapitalG (Alphabet), City Corridor Ventures, Redpoint, Echo Ventures and Ascension Ventures additionally participated within the spherical.
WHAT IT DOES
The Denver-based firm gives a value-based care platform that integrates persistent kidney illness and end-stage renal illness affected person information from numerous techniques into one platform. The expertise was designed to determine illness development and make predictions a few affected person’s situation.
The corporate additionally gives sufferers help by means of kidney transplants and dialysis, with sufferers accessing dialysis by means of conventional strategies or house hemodialysis by means of Attempt’s collaboration with Outset Medical.
The funds shall be used to broaden partnerships with Medicare, industrial and Medicare Benefit payors, physicians and well being techniques.
“With the brand new funding, we’ll proceed to develop in new markets and scale in our present markets as these grow to be extra dense. We’ll do that by refining our care mannequin, enhancing our expertise supply and scaling the enterprise throughout the U.S.,” Chris Riopelle, CEO and cofounder of Attempt, advised MobiHealthNews in an e-mail. “For the following section of firm progress, we’ll additionally proceed to draw and retain our nice staff as that is the constructing block of what makes the corporate profitable. We all know we will solely maintain different folks nicely after we maintain our personal folks, or what we name Strivers, first.”
MARKET SNAPSHOT
In 2021, Attempt Well being garnered $140 million in Series B funding led by Alphabet’s progress fund CapitalG, which was anticipated to offer the corporate “distinctive entry” to Google and Alphabet belongings.
Since then, the corporate’s partnered with nephrology group Southern California Kidney Consultants and not-for-profit Catholic healthcare system Trinity Health to enhance kidney look after sufferers.
One other firm within the kidney care area is tech-backed persistent kidney illness and end-stage renal illness administration firm Monogram Health. Monogram scored a whopping $375 million in growth funding in January, simply two years after it closed a $160 million Series B funding round,
